Mechanisms of Pregnancy Induced Hypertension
Mechanisms of Pregnancy Induced Hypertension
批准号:
6999094
负责人:
Babbette LaMarca
金额:
$4.7万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2008-07-31
关键词:
blood pressurecytokinedisease /disorder modelendothelinestrogensfemaleglomerular filtration rateinflammationinterleukin 6kidney circulationlaboratory ratpathologic processpostdoctoral investigatorpregnancy circulationpregnancy toxemia /hypertensionprogesteronesaluresistissue /cell culturetumor necrosis factor alphavascular endothelium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The objective of this research is to define the mechanisms mediating pregnancy induced hypertension. The central hypothesis to be tested in this proposal is that a reduction in uteroplacental perfusion pressure causes hypertension by reducing renal-pressure natriuresis. The reduction in pressure natriuresis occurs as a result of placental and/or leukocyte-derived cytokines causing endothelial cell activation that leads to enhanced formation of endothelin. These abnormalities reduced renal plasma flow and glomerular filtration thereby decreasing renal sodium excretory function. To test this hypothesis, arterial pressure, renal, hormonal, and endothelial function will be examined in a conscious, chronically-instrumented rat model of chronic PIH produced by long-term reductions in uterine perfusion pressure (RUPP). In addition, in vitro studies utilizing endothelial cell culture will be used to determine the interaction between inflammatory cytokines, sex steroids and endothelin production. Specific aims to be addressed are: 1) To test the hypothesis that abnormalities in cardiovascular and renal function during chronic reductions in uteroplacental perfusion pressure are due to elevations in maternal plasma levels of inflammatory cytokines such as TNF alpha and IL-6; 2) To test the hypothesis that estrogens and/or progesterone enhance the endothelial activation and hypertensive response to TNF alpha and IL-6 .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Pharmacological Treatment for Preeclampsia
-
批准号:10758980
-
项目类别:
-
资助金额:$38.53万
-
财政年份:2023
-
负责人:Babbette LaMarca
-
依托单位:
The Kidney, Hypertension, Pregnancy and Inflammation
-
批准号:8879174
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2011
-
负责人:Babbette LaMarca
-
依托单位:
The Kidney, Hypertension, Pregnancy and Inflammation
-
批准号:8681487
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2011
-
负责人:Babbette LaMarca
-
依托单位:
The Kidney, Hypertension, Pregnancy and Inflammation
-
批准号:8507262
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2011
-
负责人:Babbette LaMarca
-
依托单位:
The Kidney, Hypertension, Pregnancy and Inflammation
-
批准号:8186063
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2011
-
负责人:Babbette LaMarca
-
依托单位:
The Kidney, Hypertension, Pregnancy and Inflammation
-
批准号:8331519
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2011
-
负责人:Babbette LaMarca
-
依托单位:
Mechanisms of Pregnancy Induced Hypertension
-
批准号:7270691
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2005
-
负责人:Babbette LaMarca
-
依托单位:
Mechanisms of Pregnancy Induced Hypertension
-
批准号:7105118
-
项目类别:
-
资助金额:$5.19万
-
财政年份:2005
-
负责人:Babbette LaMarca
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KCTD10对2型免疫反应(Th2)的调控研究
-
批准号:2020JJ4441
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:任凯群
-
依托单位:
IL-6受体泛素化调控机制
-
批准号:32070775
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李姝
-
依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
-
批准号:31970735
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:江静
-
依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
-
批准号:31900556
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:林恒
-
依托单位:
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
-
批准号:81560465
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:王志刚
-
依托单位:
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
-
批准号:30870892
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2008
-
负责人:吕路线
-
依托单位: